Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. WuXi Biologics (Cayman) Inc.
  6. News
  7. Summary
    2269   KYG970081173

WUXI BIOLOGICS (CAYMAN) INC.

(2269)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CANbridge Pharmaceuticals Secures WuXi Biologics Backing for $88 Million Hong Kong IPO

11/30/2021 | 12:37am EST


ę MT Newswires 2021
All news about WUXI BIOLOGICS (CAYMAN) INC.
01/18WUXI BIOLOGICS CAYMAN : Completes GMP Inspection by South Korea's Ministry of Food and Dru..
PU
01/12WUXI BIOLOGICS CAYMAN : 40th Annual J.P. Morgan Healthcare Conference Presentation (in PDF..
PU
01/11Hong Kong shares close unchanged; Fed policy in focus
RE
01/11China stocks fall as virus worries, Fed rate hike bets weigh; Hong Kong up
RE
01/06WUXI BIOLOGICS CAYMAN : Vaccines and BravoBio Sign Letter of Intent for Long-Term Collabor..
PU
01/05China stocks fall after hawkish Fed minutes; property, consumption drop
RE
01/05Wuxi Biologics Repurchases Nearly $503 Million Worth of Shares; Shares Fall 7%
MT
2021Hong Kong shares inch up in thin trade, healthcare jumps
RE
2021WUXI BIOLOGICS CAYMAN : and ImmuneOncia Sign MOU for Development and Manufacturing of Anti..
PU
2021Wuxi Biologics and Immuneoncia Signs MOU
CI
More news
Analyst Recommendations on WUXI BIOLOGICS (CAYMAN) INC.
More recommendations
Financials
Sales 2021 9 752 M 1 537 M 1 537 M
Net income 2021 3 040 M 479 M 479 M
Net cash 2021 5 598 M 882 M 882 M
P/E ratio 2021 101x
Yield 2021 -
Capitalization 298 B 46 970 M 47 011 M
EV / Sales 2021 30,0x
EV / Sales 2022 20,5x
Nbr of Employees 7 686
Free-Float 84,2%
Chart WUXI BIOLOGICS (CAYMAN) INC.
Duration : Period :
WuXi Biologics (Cayman) Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WUXI BIOLOGICS (CAYMAN) INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 72,72 CNY
Average target price 126,55 CNY
Spread / Average Target 74,0%
EPS Revisions
Managers and Directors
Zhi Sheng Chen Director
Ming Tu Chief Financial Officer & Executive Vice President
Ge Li Non-Executive Chairman
Weichang Zhou Chief Technology Officer & Executive Director
William Robert Keller Independent Non-Executive Director
Sector and Competitors